Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Adoptive T cell therapy of solid cancers.

Keith L Knutson1, Wolfgang Wagner, Mary L Disis

  • 1Mayo Clinic College of Medicine, 342D Guggenheim, 200 First St SW, Mayo Clinic, Rochester, MN 55905, USA.

Cancer Immunology, Immunotherapy : CII
|May 14, 2005
PubMed
Summary

Adoptive T cell therapy shows promise for aggressive cancers but faces challenges in clinical translation. This review examines key issues like T cell sourcing, expansion, persistence, and activity, alongside emerging solutions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Identification of tumor-associated antigens with multi-cancer therapeutic potential.

Frontiers in immunology·2026
Same author

Predicting Durable Anti-tumor Immune Responses after Cancer Vaccines.

Journal of cancer immunology·2026
Same author

Spatially resolved single-cell landscape of tumor immunotypes reveals the central role of interferon signaling and plasmacytoid dendritic cells in triple-negative breast cancer.

Journal for immunotherapy of cancer·2026
Same author

Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer: Prognostic Significance, Predictive Value, and Emerging Directions for Clinical Implementation.

Cancers·2026
Same author

Safety and immunogenicity of a tri-antigen vaccine targeting IGFBP-2, HER2, and IGF-IR in participants with non-metastatic breast cancer.

Journal for immunotherapy of cancer·2026
Same author

Long-term cellular and humoral responses to SARS-CoV-2 vaccinations in patients with solid malignancies undergoing chemotherapy.

Frontiers in immunology·2026

Area of Science:

  • Immunology
  • Oncology
  • Cell Therapy

Background:

  • Immune-based cancer treatments are under extensive investigation.
  • Adoptive T cell therapy is a promising strategy for aggressive malignancies.
  • Preclinical models show significant potential, but clinical translation remains difficult.

Purpose of the Study:

  • To identify and review the major challenges in the clinical translation of adoptive T cell therapy.
  • To explore emerging solutions for overcoming these obstacles.

Main Methods:

  • Literature review of adoptive T cell therapy challenges and solutions.
  • Analysis of problems in sourcing, expansion, persistence, and anti-tumor activity of T cells.
  • Overview of current research addressing these issues.

Related Experiment Videos

Main Results:

  • Key problems identified include sourcing tumor-specific T cells, ex vivo expansion, in vivo persistence, and achieving sufficient anti-tumor activity.
  • Emerging solutions are being developed to address each of these critical areas.

Conclusions:

  • Overcoming the identified challenges is crucial for the successful clinical application of adoptive T cell therapy.
  • Continued research into novel strategies is essential for advancing this potent cancer treatment modality.